Press release
Investigation announced for Investors in shares of Talis Biomedical Corporation (NASDAQ: TLIS)
An investigation for investors in Talis Biomedical Corporation (NASDAQ: TLIS) shares over potential securities laws violations.
Investors who purchased shares of Talis Biomedical Corporation (NASDAQ: TLIS), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm focuses on possible claims on behalf of purchasers of the securities of Talis Biomedical Corporation (NASDAQ: TLIS) concerning whether a series of statements by Talis Biomedical Corporation regarding its business, its prospects and its operations were materially false and misleading at the time they were made.
Menlo Park, CA based Talis Biomedical Corporation operates as a molecular diagnostic company.
On or about February 12, 2021, Talis Biomedical Corporation (NASDAQ: TLIS) sold approximately 13.8 million shares of stock in its initial public stock offering (the "IPO") at $16 a share, raising nearly $221 million in new capital.
On August 10, 2021, Talis Biomedical Corporation (NASDAQ: TLIS)reported its 2nd quarter financial results. During the earnings call, it was disclosed that “In the near term, our development time lines have been extended by delays in the launching of our COVID-19 test and manufacturing scale.”
Then, on August 30, 2021, Talis announced that its President, CEO, and Director resigned.
Shares of Talis Biomedical Corporation (NASDAQ: TLIS) declined to as low as $7.01 per share on August 19 and 20, 2021.
Those who purchased shares of Talis Biomedical Corporation (NASDAQ: TLIS) have certain options and should contact the Shareholders Foundation.
Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com
About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities lawsuits, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Investigation announced for Investors in shares of Talis Biomedical Corporation (NASDAQ: TLIS) here
News-ID: 2386921 • Views: …
More Releases from Shareholders Foundation
Lawsuit Alert: Investors who lost money with James Hardie Industries plc (NYSE: …
An investor, who purchased shares of James Hardie Industries plc (NYSE: JHX), filed a lawsuit over alleged violations of Federal Securities Laws by James Hardie Industries plc in connection with certain allegedly false and misleading statements.
Investors who purchased shares of James Hardie Industries plc (NYSE: JHX) have certain options and for certain investors are short and strict deadlines running. Deadline: December 23, 2025. NYSE: JHX investors should contact the Shareholders…
Investigation announced for Long-Term Investors in SelectQuote, Inc. (NYSE: SLQT …
An investigation on behalf of current long-term investors in shares of SelectQuote, Inc. (NYSE: SLQT) concerning potential breaches of fiduciary duties by certain directors and officers of SelectQuote, Inc. was announced.
Investors who are current long term investors in SelectQuote, Inc. (NYSE: SLQT) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm for current long term…
Lawsuit filed for Investors who lost money with shares of MoonLake Immunotherape …
An investor, who purchased shares of MoonLake Immunotherapeutics (NASDAQ: MLTX), filed a lawsuit over alleged violations of Federal Securities Laws by MoonLake Immunotherapeutics in connection with certain allegedly false and misleading statements.
Investors who purchased a significant amount of shares of MoonLake Immunotherapeutics (NASDAQ: MLTX) between March 10, 2024 and September 29, 2025, have certain options and for certain investors are short and strict deadlines running. Deadline: December 15, 2025. NASDAQ:…
Dow Inc. (NYSE: DOW) Investor Alert: Deadline in Lawsuit on October 28, 2025
A deadline is coming up on October 28, 2025 in the lawsuit filed for certain investors of Dow Inc. (NYSE: DOW) over alleged securities laws violations by Dow Inc.
Investors who purchased shares of Dow Inc. (NYSE: DOW) have certain options and there are strict and short deadlines running. Deadline: October 28, 2025. Dow Inc. (NYSE: DOW) stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 -…
More Releases for Talis
Optimal Reptile Care with Talis-us: Premium Products for Health and Comfort
Talis-us specializes in a wide array of products tailored for reptiles, emphasizing their health and comfort. From essential lighting mimicking natural sunlight to heating solutions ensuring proper temperature gradients, Talis-us offers diverse food options. With a commitment to quality and customer education, Talis-us supports reptile owners in providing optimal care.
Image: https://www.getnews.info/uploads/bdb2abd5aa8fd356b5fa2dcfb4aa4163.png
Talis-us offers a large selection of items that are made to specifically address the needs of reptiles [https://talis-us.com/blogs/news/talis-us-reptile-supply-quality-products-for-your-reptile-needs]. The…
Investigation announced for Investors in shares of Talis Biomedical Corporation …
An investigation was announced for investors of Talis Biomedical Corporation (NASDAQ: TLIS) shares over potential securities laws violations by Talis Biomedical Corporation.
Investors who purchased shares of Talis Biomedical Corporation (NASDAQ: TLIS), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm focuses on whether a series of statements by Talis Biomedical Corporation regarding its business, its prospects and…
Gate Shut-Off Valve Market ; Eminent Players - Schneider Electric, Johnson Contr …
In the past few years, the Gate Shut-Off Valve market experienced a huge change under the influence of COVID-19 and Russia-Ukraine War, the global market size of Gate Shut-Off Valve reached the predicted milestone in 2022 with the rising CAGR from 2017-2022. Facing the complicated international situation, the future of the Gate Shut-Off Valve market is full of uncertain. Report predicts that the global Gate Shut-Off Valve market size will…
Investigation announced for Long-Term Investors in shares of Talis Biomedical Co …
An investigation was announced over possible breaches of fiduciary duties by certain directors of Talis Biomedical Corporation.
Investors who are current long term investors in Talis Biomedical Corporation (NASDAQ: TLIS) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm for current long term investors in NASDAQ: TLIS stocks follows a lawsuit filed against Talis Biomedical Corporation…
Deadline on March 8th in Lawsuit for Investors in Talis Biomedical Corporation ( …
The Shareholders Foundation announced that a deadline is coming up on March 8, 2021 in the lawsuit filed for certain investors of Talis Biomedical Corporation (NASDAQ: TLIS).
Investors who purchased shares of Talis Biomedical Corporation (NASDAQ: TLIS) have certain options and there are strict and short deadlines running. Deadline: March 8, 2021. Talis Biomedical Corporation (NASDAQ: TLIS) stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
According…
Lawsuit filed for Investors in shares of Talis Biomedical Corporation (NASDAQ: T …
An investor, who purchased shares of Talis Biomedical Corporation (NASDAQ: TLIS), filed a lawsuit over alleged Securities Laws violations by Talis Biomedical Corporation in connection with the Company’s February 2021 initial public offering (“IPO”).
Investors who purchased shares of Talis Biomedical Corporation (NASDAQ: TLIS) have certain options and for certain investors are short and strict deadlines running. Deadline: March 8, 2021. NASDAQ: TLIS investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com…
